Lotus Pharmaceuticals (LTUS) Stock Chart & Stock Price History $0.0072 +0.00 (+24.14%) As of 06/17/2025 10:00 AM Eastern Add Compare Share Share Chart Stock AnalysisChartHeadlinesShort InterestBuy This Stock Lotus Pharmaceuticals Stock Price Performance The Lotus Pharmaceuticals (LTUS) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 118.18%, with a year-to-date return of 20.00%. In the past month, the stock has increased 35.85%, reflecting recent market activity. As of the latest close, Lotus Pharmaceuticals traded at $0.01 with a market cap of $19.04 million and volume of 12,662 shares. Receive LTUS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Lotus Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+4.35%1 Month Performance+35.85%3 Month Performance-7.69%Year-To-Date Performance+20.00%1 Year PerformanceN/A LTUS Stock Chart for Wednesday, June, 18, 2025 LTUS Chart by TradingView Lotus Pharmaceuticals Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization06/17/2025$0.01$0.01+24.14%$0.01$0.0112,662 shs$19.04 million06/16/2025$0.01$0.01-15.94%$0.01$0.0164,000 shs$15.34 million06/13/2025$0.01$0.01-12.66%$0.01$0.01627 shs$18.25 million06/12/2025$0.01$0.01+9.72%$0.01$0.0135,952 shs$20.89 million06/11/2025$0.01$0.01$0.01$0.0189,718 shs$19.04 million06/10/2025$0.01$0.01+44.00%$0.01$0.0189,718 shs$19.04 million06/09/2025$0.01$0.01$0.01$0.0190,000 shs$13.22 million06/06/2025$0.01$0.01-15.25%$0.01$0.01186,210 shs$13.22 million06/04/2025$0.01$0.01$0.01$0.0164,516 shs$15.60 million06/03/2025$0.01$0.01-4.84%$0.01$0.0164,516 shs$15.60 million Get the Latest News and Ratings for LTUS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Lotus Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 06/02/2025$0.01$0.01$0.01$0.0160,330 shs$16.40 million05/30/2025$0.01$0.01+6.90%$0.01$0.01116,636 shs$16.40 million05/29/2025$0.01$0.01$0.01$0.0175,549 shs$15.34 million05/28/2025$0.01$0.01-6.45%$0.01$0.0170,000 shs$15.34 million05/27/2025$0.01$0.01+6.90%$0.01$0.0120,000 shs$16.40 million05/26/2025$0.01$0.01$0.01$0.00140,906 shs$15.34 million05/23/2025$0.00$0.01+31.82%$0.01$0.00140,906 shs$15.34 million05/22/2025$0.00$0.00$0.00$0.002,200 shs$11.64 million05/21/2025$0.00$0.00$0.00$0.002,200 shs$11.64 million05/20/2025$0.01$0.00-26.67%$0.00$0.002,200 shs$11.64 million05/19/2025$0.01$0.01+13.21%$0.01$0.0116,275 shs$15.87 million Related Companies IGMS Stock Price Chart GNTA Stock Price Chart IMRX Stock Price Chart INCR Stock Price Chart SNTI Stock Price Chart ARMP Stock Price Chart STRO Stock Price Chart VNRX Stock Price Chart IMMX Stock Price Chart MCRB Stock Price Chart Receive LTUS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Lotus Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (OTCMKTS:LTUS) was last updated on 6/18/2025 by MarketBeat.com Staff From Our PartnersBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe one deadline Elon can't afford to miss...For years, Elon Musk made headlines for blowing past deadlines — so often that investors coined a nickname for...Brownstone Research | SponsoredWhat 99% of investors are missing about Chinese AIChinese AI chatbot DeepSeek's release put the spotlight on AI and turned the tech world on its head. But 99...Weiss Ratings | SponsoredTop Picks for Trump’s Pro-Crypto AmericaMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredWhen This Happens, You Don’t Wait. You Act.This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lotus Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lotus Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy LTUS Stock Free LTUS Stock Alerts